In the ever-evolving realm of pharmaceuticals, where innovation and social responsibility intertwine, Leena Tewari stands out as a force to be reckoned with. The chairperson of USV Private Limited, a multinational pharmaceutical and biotechnology company, Tewari's story isn't a narrative of sudden success, but rather a testament to quiet determination, strategic vision, and a deep-rooted commitment to improving lives. Today, we delve into the life and work of this exceptional leader, exploring the guiding principles behind her remarkable journey and the valuable lessons we can glean from her success.
Leena Tewari's story is intrinsically linked to her family's legacy. Born into a family with a rich history in pharmaceuticals – her grandfather founded USV in 1961 – Tewari wasn't simply handed the reins. She witnessed firsthand the dedication and values that fueled the company's growth. As Tewari herself once remarked,
"Building a successful company is commendable, but building a company that makes a positive impact is truly fulfilling."
This philosophy became the cornerstone of her leadership approach.
Her journey began with a solid educational foundation. Tewari earned a Bachelor of Commerce degree from the University of Mumbai and went on to pursue a Master of Business Administration from Boston University. This blend of business acumen and global perspective equipped her with the tools necessary to navigate the complexities of the pharmaceutical industry.
Upon returning to India, Tewari didn't simply take over the reins at USV. She immersed herself in the company's operations, gaining a deep understanding of its strengths and weaknesses. She championed a focus on research and development, ensuring USV remained at the forefront of innovative drug development. However, Tewari's vision extended far beyond the bottom line. She recognized the critical role pharmaceuticals play in public health, particularly in a country like India.
Under her leadership, USV prioritized the development of affordable medications for cardiovascular and diabetic conditions, ailments that plague millions in India. This commitment to social responsibility not only garnered acclaim but also ensured USV's long-term sustainability. Under her leadership, USV has evolved from an importer of medicines to a manufacturing company, including a significant partnership with Revlon. Tewari's strategic vision led to the acquisition of the German generics company Juta Pharma in 2018, reflecting her ambitions for international expansion. Leena Tewari's dedication to philanthropy further solidified her image as a leader driven by a higher purpose. She actively supports causes that empower underprivileged women and champions initiatives that improve access to education and healthcare for underprivileged communities.
So, what exactly has Leena Tewari done right? Let's explore the key ingredients of her success:
Building on Legacy: Tewari respected the rich history of USV, but she wasn't afraid to chart her own course for the company's future.
Focus on Innovation: She championed research and development, ensuring USV remained at the cutting edge of pharmaceutical advancements.
Social Responsibility: Tewari prioritized the development of affordable medications for critical health conditions, making a positive impact on millions.
Strategic Philanthropy: Her dedication to social causes like women's empowerment and healthcare access garnered respect and admiration.
Long-Term Vision: Tewari focused on sustainable growth for USV, ensuring its continued success for generations to come.
Here are some valuable takeaways we can harvest from Leena Tewari's journey:
Respect your roots: Learn from the past and build upon the foundation laid by those who came before you.
Embrace innovation: The world is constantly evolving; prioritize research and development to stay ahead of the curve.
Give back to society: Use your success to make a positive impact on the lives of others.
Lead with purpose: Don't just chase profits; find a higher calling for your organization.
Think for the future: Make decisions that ensure the long-term sustainability of your endeavours.
Awards and Achievements
Her efforts haven't gone unnoticed. Tewari has been recognized by the Hurun Report India Philanthropy List for her significant contributions. Her philanthropic efforts are equally significant, with her donation of ₹34 crores (approximately US$4 million) in 2019, earning her the 3rd rank in the Women Philanthropists of 2019 by the Hurun Report India Philanthropy List. While awards and accolades aren't the sole measure of Tewari's success, they do serve as a testament to her remarkable leadership. USV, under her stewardship, has grown into a multinational pharmaceutical giant, consistently ranking among the top five pharmaceutical companies in India. Despite her achievements, Tewari maintains a relatively low profile, shying away from the limelight and focusing on the meticulous growth of USV. Tewari is an avid reader and writer, with a passion for dance and nature, particularly wildlife and forest explorations. Her writing includes a biography of her grandfather, ‘Beyond Pipes & Dreams – The Life of Vithal Balkrishna Gandhi’, which demonstrates her dedication to preserving family heritage.
Conclusion
In the grand tapestry of India's business landscape, Leena Tewari emerges as a luminary whose legacy transcends mere business success. Her unwavering commitment to innovation, integrity, and social responsibility has not only propelled her company to unparalleled heights of success but also empowered communities and fostered sustainable development. As we reflect on her remarkable journey, let us draw inspiration from her indomitable spirit and unwavering commitment to excellence, aspiring to emulate her ethos of resilience, innovation, and impact. In the words of Leena Tewari herself,
"Success is not just about achieving your goals; it's about making a difference in the lives of others and leaving behind a legacy that inspires future generations."
Logon to https://tikonacapital.smallcase.com/ to know more
Sumit Poddar
Chief Investment Officer & Smallcase Portfolio Manager
Tikona Capital
Comments